Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit

<p>BOSTON, Nov. 22, 2023 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of T cell engagers to selectively modulate tumor-specific T cells, announced today that it will take part in a fireside chat at the JMP Securities Hematology and Oncology Summit being held virtually from December 5-6, 2023. […]</p>
<p>The post <a href="https://forextv.com/top-news/cue-biopharma-to-present-at-the-jmp-securities-hematology-and-oncology-summit/">Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>